Author

PK Epling-Burnette

Observed name: P.K. Epling-Burnette

Institution: AbbVie (United States)

Observed institution: AbbVie (United States)

OpenAlex ID: A5031376109

Bivalent BCMA Binding and Low Affinity CD3 T-Cell Engagement By Abbv-383 Drives Sustained Activation with Reduced T-Cell Exhaustion in Preclinical Models of Multiple Myeloma

2023 · David Sharon, Valerie Robinson, et al. · Blood · 10

Evaluation of Epcoritamab and Rituximab Combination in Preclinical Models of B-Cell Non-Hodgkin's Lymphoma (NHL)

2022 · PK Epling-Burnette, Durga B Dandamudi, et al. · Blood · 5

Abstract 2530: DELE1 loss and dysfunctional integrated stress signaling in TP53 mutated AML is a novel pathway for venetoclax resistance

2023 · David Sharon, Paul Jung, et al. · Cancer Research · 2

Abstract 540: c-MET mutations sensitize to antibody-drug conjugate telisotuzumab vedotin through efficient internalization and rapid intracellular drug delivery

2023 · Izhar S. Batth, Bijay S. Jaiswal, et al. · Cancer Research · 2

Abstract 2116: Telisotuzumab vedotin (Teliso-V)-mediated c-Met internalization, endolysosomal trafficking, and potent cytotoxic activity are unaffected by MET exon-14 skipping mutation

2024 · Izhar Batth, Ronald Pandoy, et al. · Cancer Research · 1

Abstract 663: TOP1i-ADC demonstrates immune-stimulating activity in colorectal cancer explants.

2026 · Irene I. Lee, Durga B. Dandamudi, et al. · Cancer Research

Exposure to epcoritamab is associated with improved T-cell functionality and dynamic changes in CD8+ T-cells in diffuse large B-cell lymphoma: Insights from epcore NHL-6

2025 · Gregory Takacs, Pingping Zheng, et al. · Blood

T-cell engager activity of etentamig (BCMA x CD3) is potentiated by daratumumab in preclinical models of multiple myeloma

2025 · David Sharon, Valerie Robinson, et al. · Blood

Clinical Genomic Analyses Demonstrate t(11;14) Multiple Myeloma Retains B-Cell Biology and Distinct Mitochondrial Metabolism That Convey Increased Sensitivity to BCL-2 Inhibition By Venetoclax

2022 · David Sharon, Fengjiao Dunbar, et al. · Blood

Works count: 9

Citation count: 20

H-index: 2

I10-index: 1